Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Randomized, Double Masked, Placebo Controlled Clinical Study to Assess the Efficacy and Safety of TOP1630 0.1% Ophthalmic Solution Compared to Placebo in Subjects With Moderate to Severe Dry Eye Syndrome

NCT03833388 is registered in ClinicalTrials.gov with Topivert Pharma Ltd as lead sponsor.

NCT NCT03833388
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03833388 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Randomized, Double Masked, Placebo Controlled Clinical Study to Assess the Efficacy and Safety of TOP1630 0.1% Ophthalmic Solution Compared to Placebo in Subjects With Moderate to Severe Dry Eye Syndrome
Lead sponsor
Topivert Pharma Ltd
Phase
Phase 2/3
Overall status
Completed
Start date
February 13, 2019
Completion date
May 14, 2019
Enrollment
202 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye syndrome